PaLM Conf Minutes 2016-Mar-09

From IHE Wiki
Revision as of 11:35, 15 March 2016 by Cknapik (talk | contribs) (→‎Attendees)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Back to IHE Pathology and Laboratory Medicine (PaLM) Domain

Back to IHE Pathology and Laboratory Medicine (PaLM)Technical Committee Page

Recording

Recording available for download at


Attendees

Francois Macary ASIP Sante
Carolyn Knapik CAP, secretariat
Dmytro Rudd Roche
James Harrison CAP
Raj Dash CAP
Riki Merrick APHL
Laurent Lardin BioMerieux
Mary Kennedy CAP, secretariat
Megumi Kondo Sakura Finetek
Naomi Ishii JAHIS
Benoit Denisselle Beckman Coulter
James Wulkan Beckman Coulter
JD Nolen Cerner
Alessandro Sulis CRS4
Mark Law mTuitive
Daniel Rutz Epic
Francesca Frexia CRS4
Gunter Haroske IHE Germany

Minutes

Agenda link: http://wiki.ihe.net/index.php?title=PaLM_Conf_Agenda_2016-Mar-09-Agenda


  • Housekeeping: Updates & checks on wiki, roster, milestones page – all
    • Roster should be available for next call. Could be a google spreadsheet, like IHE DCC does. More convenient for keeping it up to date.
    • Milestones page is now updated.
    • When there are no technical topics for agenda, call will be limited to first hour.
  • Comment on XD-LAB made regulatory in France as of 2016 – François
    • The regulatory framework points the interoperability framework, and precisely, the specification which represents IHE XD-LAB in French. If the specification evolves, the regulatory framework is still valid: It points to the applicable version of the specification, hence the last one.
  • Comment on LAW team contribution to IHE conformity assessment scheme
    • LAW almost ready for conformity assessment testing. The review of the CAS requested by Anne-Gaëlle, was performed by Riki, Ed and François.
  • Discussion on SET detailed proposal (scope and specimen model …) – Alessandro
    • The proposal was shared incomplete so to have discussion
    • 1 single transaction and a pair of actors. Grouping of SET actors with actors of all profiles (LTW, LBL, LAW, ...)
    • Alessandro explains the major issues of discussion:
      • Issue 1: the scope of the profile: Which use cases?
        • Initial scope:
          • Workflow of specimen collection that are not completely covered in LBL profile, which is why we want to have SET
          • Exceptions to handling process when SOP was not followed, environmental conditions the specimen was exposed to (in biobanking, but not in clinical system) – example: androgen receptors on prostate samples – storage
          • Review ALL profiles in the PaLM domain to see, if any of these are already covered, or have other use cases related to specimen
          • LAW has some points of interest about specimen – specimen arrives at automation part
        • EPIC: Transitions of specimens across labs, across organizations
        • Raj: Workflows related to biobanking à needs additional data elements in the model. See the Specimen DAM project of HL7 and send feedback. Biobanking is not only for research. It’s used for all the genomics, in clinical labs.
        • JD: biobanking -> picking new identifiers
      • Issue 2: Which version of standard? V2? V3? FHIR?
        • To answer: check that SPM content from V2 is sufficient.
        • Check message type. Alternative could be SSUID?
      • Step 1: Consolidate the scope, use cases and related data analysis. Then, have a consensus on that.
      • Step 2: Select the most appropriate standard.
      • All sources of information to consolidate step 1 are welcome to be shared on the PaLM googleGroup.
    • April call will be one week earlier, because of the European connectathon.
    • Agenda items for April 6th call:
      • SET (share materials a week prior to call)
      • White paper discussion (Raj)
      • F2F agenda May 23 – 25 Berlin, Germany
      • LSH Deep Dive (John Hopson)

 

 

Retrieved from "http://wiki.ihe.net/index.php?title=PaLM_Conf_Minutes_2016-Mar-09&oldid=93201"